Imagine a world where the time from discovery to treatment takes months, not years. A world where therapies aren’t just a response to a disease but evolve alongside them—adapting with precision and speed to meet emerging threats. At Mabloc this isn’t just a vision of the future—it’s what we are building today.
For decades, the pace of medical breakthroughs has often been outpaced by the diseases they’re meant to treat. Pathogens mutate faster than traditional drug development can manage, leaving healthcare systems stretched and patients waiting for new treatments. At Mabloc, we knew this needed to change. So, we asked: how can we change the way therapies are discovered so treatments keep pace with the evolving nature of diseases?
Our answer is BRAID™, an antibody discovery platform that leverages AI and bioinformatics. BRAID™ is different because of its ability to process millions of antibody sequences and quickly identify those with the highest potential for treating complex diseases. It does so with the kind of speed and precision that changes the way we think about the timelines needed to bring new therapies to patients.
In the past, identifying the most effective antibodies from a large dataset could take years of manual effort. With BRAID™, AI speeds up this process, analyzing data much faster, identifying potential candidates, and optimizing them for therapeutic use. We’re not just making the process quicker—we’re fundamentally rethinking how timelines in drug discovery work.
At Mabloc, our approach to discovery is comprehensive. Using AI, our platform refines and optimizes antibodies, improving their potency, stability, and adaptability. This ensures that the therapies we develop are effective not only for today’s health challenges but also equipped to address the evolving threats of tomorrow.
To go from millions of sequences to viable therapies faster than ever before is at the core of what we do. It’s not just about speed for speed’s sake—it’s about meeting the urgent needs of healthcare. The faster we can bring therapies from discovery to clinical trials, the sooner patients receive the treatments they need.
Looking ahead, we envision a future where new breakthroughs aren’t held back by outdated methods. Instead, they meet the demands of modern healthcare. With BRAID™, Mabloc is building a future where innovation and adaptability shape what’s possible in medicine.
We are not only discovering new therapies—we’re delivering them at the speed and scale of AI, making sure they reach patients faster than ever before.
Welcome to Mabloc. Welcome to the future of therapeutics, at the speed and scale of AI.
Sincerely,
Michael Wyand
CEO, Mabloc
